COMPOSITION HÉMOSTATIQUE

European patent · EP4593901 · In force

Register entry

Publication number
EP4593901
Application number
EP23782513
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 28, 2023
Published
Aug 6, 2025
Granted
Jul 8, 2026
Protection ends at the latest
Sep 27, 2043
Next annual fee due
Sep 30, 2027
IPC classes
A61L 26/00 (2006.01)
Priority
EP 22199052 30.09.2022
EP 23183548 05.07.2023
PCT application
PCT/EP2023/076884 28.09.2023
PCT publication
WO2024/068836 04.04.2024
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 2, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 02.10.2026

  2. Jul 13, 2026

    Agent entered

    Representative
    Stolmár & Partner Intellectual Property S.à.r.l., Bahnhofstrasse 11, 6210 Sursee

    Published in Swissreg on 13.07.2026

  3. Jul 8, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 08.07.2026

Parties

Holder

Ferrosan Medical Devices A/S

Sydmarken 5, 2860 Søborg, DK

Agent

Stolmár & Partner Intellectual Property S.à.r.l.

Bahnhofstrasse 11, 6210 Sursee

Inventor

HAMMERSHØJ, Peter Lund

2860 Søborg, DK

BHATIA, Vikram Kjøller

2860 Søborg, DK

BEJENARIU, Anca Gabriela

2860 Søborg, DK

ABID, Urshan

2860 Søborg, DK

JENNUM, Camilla Arboe

2860 Søborg, DK

KLODZINSKA, Sylvia Natalie

2860 Søborg, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.